Systemic Administration of Interleukin-10 Attenuates Early Ischemic Response Following Spinal Cord Ischemia Reperfusion Injury in Rats
JOURNAL OF SURGICAL RESEARCH, cilt.155, sa.2, ss.345-356, 2009 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Derleme
- Cilt numarası: 155 Sayı: 2
- Basım Tarihi: 2009
- Doi Numarası: 10.1016/j.jss.2008.07.013
- Dergi Adı: JOURNAL OF SURGICAL RESEARCH
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.345-356
- Anahtar Kelimeler: spinal cord, ischemia, reperfusion injury, cytokine, interleukin-10, interleukin-1 beta, inflammation, central nervous system, lipid peroxidation, myeloperoxidase, TUMOR-NECROSIS-FACTOR, CENTRAL-NERVOUS-SYSTEM, ANTIINFLAMMATORY CYTOKINE, AORTIC OCCLUSION, MESSENGER-RNA, BRAIN-INJURY, MYELOPEROXIDASE ACTIVITY, INFLAMMATORY CYTOKINES, CEREBRAL-ISCHEMIA, FOCAL STROKE
- Hacettepe Üniversitesi Adresli: Evet
Özet
Background. The aim of this experimental study was to investigate the early effects of interleukin-10 (IL-10) and interleukin-1 beta antagonist (anti-IL-1 beta) against cellular damage, inflammatory reactivity, lipid peroxidation (LPO), and myeloperoxidase (MPO) activity induced by spinal cord ischemia reperfusion injury (IRI).